Abstract:Objective To investigate the role of calcium/calmodulin-dependent protein kinase Ⅱ (CaMK Ⅱ) in the primary somatosensory area (S1 area) and hippocampi in reduction of remifentanil-induced hyperalgesia by lidocaine in rats.Methods One hundred fifty-six male Sprague-Dawley rats,aged 8-10 weeks,weighing 240-260 g,were randomly allocated into 4 groups using a radom number table:control group (group C,n=6),remifentanil group (group R,n=50),lidocaine group (group L,n=50),and remifentanil+lidocaine group (group RL,n =50).Remifentanil was given as a bolus of 6 mg/kg followed by an 2 h infusion of 2.4 μg · kg-1 · min-1 in group R.Lidocaine was given as a bolus of 6 mg/kg followed by an infusion of 200 μg · kg-1 · min-1 for 2 h in group L.In group RL,drug administration was similar to those previously described in R and L groups.The mechanical paw withdrawal threshold (MWT) and thermal paw withdrawal latency (TWL) were measured before administration and at 0.5,2,5 and 24 h after the end of administration.The rats were then sacrificed immediately after administration and at 0.5,2,5 and 24 h after the end of administration in R,L and RL groups,or at the corresponding time point in group C.The S1 area and hippocampi were isolated for determination of phosphorylated CaMK Ⅱ (p-CaMK Ⅱ) expression by Western blot.Results Compared with the value before administration,the MWT was significantly decreased at 0.5 and 2 h after the end of administration (P＜0.05),and no significant change was found in TWL at each time point after the end of administration in R,L and RL groups (P＞0.05).Compared with group C,p-CaMK Ⅱ expression in the S1 area and hippocampi was significantly up-regulated immediately after administration and at 0.5 and 2 h after the end of administration in group R (P＜0.05).Compared with group R,p-CaMK Ⅱ expression in the S1 area and hippocampi was significantly down-regulated immediately after administration and at 0.5 and 2 h after the end of administration in group RL,and p-CaMK Ⅱ expression in the S1 area was significantly down-regulated immediately after administration,and at 0.5 and 2 h after the end of administration,and p-CaMK Ⅱ expression in the hippocampi was down-regulated immediately after administration,and at 0.5,2 and 24 h after the end of administration in group L,and MWT was increased at 0.5 and 2 h after the end of administration in groups L and RL (P＜0.05).There was no significant difference in TWL at each time point among the three groups (P＞0.05).Conclusion The mechanism by which lidocaine mitigates remifentanil-induced hyperalgesia is associated with inhibited activity of CaMKII in the S1 area and hippocampi of rats.

Effects of Different Dose of KN93 on Remifentanil-Induced Hyperalgesia

Effects of CaMK Ⅱ Inhibitor KN93 on Remifentanil-Induced Hyperalgesia

Dezocine Attenuates the Remifentanil-Induced Postoperative Hyperalgesia by Inhibition of Phosphorylation of CaMKⅡα.

Ketamine Reduces Remifentanil-Induced Postoperative Hyperalgesia Mediated by CaMKII-NMDAR in the Primary Somatosensory Cerebral Cortex Region in Mice.

The Preventive Effect of Intrathecal KN93 or Ifenprodil Administration on Remifentanil-Induced Incisional Hyperalgesia

Intrathecal Injection of KN93 Attenuates Paradoxical Remifentanil-Induced Postoperative Hyperalgesia by Inhibiting Spinal CaMKII Phosphorylation in Rats

Antinflammatory pain effect of ifenprodil administrated subarachnoidly

Effect of ketamine on remifentanil induced hyperalgesia in incision pain rats

Effect of intrathecal injection of KN93 on pain behaviors in rats with neuropathic pain

Effects of Intrathecal Morphine on Excitatory Amino Acid Contents of Spinal Cord in a Rat Model of Incision Pain

The Influence of Ketamine on KCC2 in Spinal Cord of Rat in Remifentanil-Induced Hyperalgesia

Effects of Ketamine Pretreatment on Preventing Remifentanil-Induced Hyperalgesia

Effects of Dexmedetomidine on Remifentanil-Induced Hyperalgesia in a Rat Model of Incisional Pain

Effects of Intrathecal Injection of Different Dose of Protein Kinase B Inhibitor IV on Hyperalgesia Induced by Remifentanil

Phosphorylated CaMKII Levels Increase in Rat Central Nervous System after Large-Dose Intravenous Remifentanil

Role of CaMK Ⅱ in primary somatosensory area and hippocampi in reduction of remifentanil-induced hyperalgesia by lidocaine in rats

Influence of dexmedetomidine on expressions of PKCγ, CaMKⅡαand pCaMKⅡαin spinal cord in rats with hyperalgesia

Effect of Intrathecal Injection JWH015 on the Remifentani-Induced Hyperalgesia in Rats

Effect of Verapamil on Expression of K+·Cl-cotransporter 2 in Spinal Dorsal Horns During Remifentanil-Induced Hyperalgesia in a Rat Model of Incisional Pain

Effects of Akt inhibitor Ⅳ on prevention and treatment the hyperalgesia induced by remifentanil

Role of CaMK II in primary somatosensory area and hippocampi in reduction of remifentanil-induced hyperalgesia by lidocaine in rats